Gene: EXTL3
Official Full Name: exostosin like glycosyltransferase 3provided by HGNC
Gene Summary: This gene encodes a single-pass membrane protein which functions as a glycosyltransferase. The encoded protein catalyzes the transfer of N-acetylglucosamine to glycosaminoglycan chains. This reaction is important in heparin and heparan sulfate synthesis. Alternative splicing results in the multiple transcript variants. [provided by RefSeq, Nov 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07389 | EXTL3 Knockout cell line (HeLa) | Human | EXTL3 | 1:3~1:6 | Negative | Online Inquiry |
KO07390 | EXTL3 Knockout cell line (HCT 116) | Human | EXTL3 | 1:2~1:4 | Negative | Online Inquiry |
KO07391 | EXTL3 Knockout cell line (HEK293) | Human | EXTL3 | 1:3~1:6 | Negative | Online Inquiry |
KO07392 | EXTL3 Knockout cell line (A549) | Human | EXTL3 | 1:3~1:4 | Negative | Online Inquiry |
EXTL3 Gene Knockout Cell Lines are specialized cellular models engineered to completely disrupt the expression of the EXTL3 gene, which encodes an enzyme involved in the biosynthesis of glycosaminoglycans and influences multiple biological processes, including cell signaling and development. By using advanced CRISPR-Cas9 gene-editing technology, these cell lines allow researchers to investigate the physiological roles of EXTL3 and its contribution to various disease states, including cancer and developmental disorders.
The primary function of EXTL3 Gene Knockout Cell Lines is to serve as a reliable platform for functional studies, allowing scientists to elucidate the pathways affected by the loss of EXTL3 expression. This is particularly crucial in understanding how glycosaminoglycan metabolism is altered in pathological conditions. The mechanisms whereby EXTL3 operates involve its interaction with other glycosyltransferases and the extracellular matrix, making it a critical component in tissue architecture and cell-matrix interactions.
In research settings, EXTL3 knockouts provide invaluable insights into gene function and can help identify potential therapeutic targets. Clinically, these cell lines can be used for drug screening and biomarker discovery, facilitating the development of novel treatment strategies based on glycosaminoglycan modulation.
What sets our EXTL3 Gene Knockout Cell Lines apart from alternatives is their high specificity and efficiency, significantly reducing off-target effects typically associated with traditional gene-manipulation methods. Additionally, our cell lines undergo rigorous validation and provide consistent performance across multiple assays, ensuring reliable and reproducible results for varied research applications.
Researchers and clinicians will find value in adopting these cell lines as they represent a cutting-edge tool for dissecting complex biological mechanisms in a controlled environment. Our company, with a strong commitment to advancing biotechnological tools and resources, ensures that each product meets the highest standards of scientific rigor and quality. We strive to empower the research community by providing innovative solutions that accelerate discovery in genomics and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.